Cat. #151823
Anti-TRF2 [SWE38]
Cat. #: 151823
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: human TRF2
Class: Polyclonal
Application: ChIP ; IF ; WB
Reactivity: Human
Host: Rabbit
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Stephen West
Institute: Cancer Research UK, London Research Institute: Clare Hall Laboratories
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-TRF2 [SWE38]
- Research fields: Cancer;Genetics
- Clone: SWE38
- Tool sub type: Primary antibody
- Class: Polyclonal
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Rabbit
- Application: ChIP ; IF ; WB
- Description: TRF2 (also known as TERF2), is a component of the telomere nucleoprotein complex. Binds the telomeric double-stranded 5'-TTAGGG-3' repeat and plays a central role in telomere maintenance and protection against end-to-end fusion of chromosomes.
- Immunogen: His tagged full length recombinant TRF2 (from baculovirus)
- Recommended controls: Hela S1.2.11
Target Details
- Target: human TRF2
- Tissue cell line specificity: Hela S1.2.11
- Target background: TRF2 (also known as TERF2), is a component of the telomere nucleoprotein complex. Binds the telomeric double-stranded 5'-TTAGGG-3' repeat and plays a central role in telomere maintenance and protection against end-to-end fusion of chromosomes.
Applications
- Application: ChIP ; IF ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: Whole serum
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Tarsounas et al. 2004. Cell. 117(3):337-47. PMID: 15109494.
- Telomere maintenance requires the RAD51D recombination/repair protein.
- Tarsounas et al. 2003. Oncogene. 22(8):1115-23. PMID: 12606939.
- BRCA2-dependent and independent formation of RAD51 nuclear foci.
